Arcutis Biotherapeutics Inc (ARQT) Insider Trading

Total insider buys:
  • $26,579,888.32
Total insider sells:
  • $24,425,732.15
Most recent insider trade:
  • Nov. 15, 2024
Most active insider trader:
  • Todd Franklin Watanabe
Trader NameDateTitleAmountPriceTypeTotal Value
Nov. 15, 2024Insider100$10.03Sell$1,003.00
Nov. 11, 2024Director8,687$10.85Sell$94,253.95
Nov. 4, 2024Insider5,015$8.68Sell$43,530.20
Nov. 1, 2024Director10,000$8.65Sell$86,500.00
Oct. 2, 2024SVP3,725$10.01Sell$37,287.25
Oct. 1, 2024Director10,000$9.26Sell$92,600.00
Sept. 24, 2024CFO11,626$9.48Sell$110,214.48
Sept. 3, 2024Director10,000$10.77Sell$107,700.00
Aug. 19, 2024Insider1,728$8.29Sell$14,325.12
Aug. 2, 2024Insider5,220$9.02Sell$47,084.40
Aug. 1, 2024Director10,000$9.87Sell$98,700.00
July 1, 2024Director10,000$9.31Sell$93,100.00
May 30, 2024Insider23,000$8.75Sell$201,250.00
May 28, 2024Insider1,775$9.01Sell$15,992.75
May 17, 2024SVP7,640$8.98Sell$68,607.20
March 4, 2024Insider3,760$11.12Sell$41,811.20
Jan. 2, 2024Insider1,325$3.54Sell$4,690.50
Nov. 21, 2023Insider1,850$1.98Sell$3,663.00
Oct. 24, 2023Major Shareholder80,000$2.50Buy$200,000.00
Aug. 21, 2023Insider1,605$7.04Sell$11,299.20
May 31, 2023Insider1,830$7.80Sell$14,274.00
April 17, 2023Director8,500$13.97Sell$118,745.00
April 6, 2023Director8,500$12.01Sell$102,085.00
March 6, 2023Insider2,435$15.26Sell$37,158.10
March 6, 2023CFO291$15.26Sell$4,440.66
March 6, 2023SVP831$15.26Sell$12,681.06
March 2, 2023Insider5,472$15.83Sell$86,621.76
March 2, 2023CFO1,434$15.83Sell$22,700.22
March 2, 2023SVP1,432$15.83Sell$22,668.56
Feb. 28, 2023Insider2,343$16.17Sell$37,886.31
Feb. 28, 2023CFO416$16.17Sell$6,726.72
Feb. 28, 2023SVP936$16.17Sell$15,135.12
Feb. 15, 2023Director8,500$16.98Sell$144,330.00
Feb. 13, 2023Insider483$17.00Sell$8,211.00
Jan. 17, 2023Director8,500$13.72Sell$116,620.00
Jan. 3, 2023Insider1,475$15.01Sell$22,139.75
Dec. 7, 2022Insider1,000$17.06Sell$17,060.00
Nov. 21, 2022Insider1,720$18.19Sell$31,286.80
Nov. 7, 2022Insider1,000$18.00Sell$18,000.00
Oct. 7, 2022CEO1,000$19.51Sell$19,510.00
Oct. 4, 2022Director6,000$20.29Sell$121,740.00
Sept. 7, 2022CEO1,000$21.51Sell$21,510.00
Aug. 15, 2022Director6,000$24.80Sell$148,800.00
July 18, 2022N/A6,000$24.40Sell$146,400.00
July 18, 2022Director6,000$24.40Sell$146,400.00
July 8, 2022President and CEO1,500$25.00Sell$37,500.00
July 8, 2022Chief Technical Officer2,197$25.41Sell$55,825.77
July 6, 2022CEO1,000$22.07Sell$22,070.00
June 24, 2022Major Shareholder341,971$21.31Sell$7,287,402.01
June 2, 2022SVP1,795$19.73Sell$35,415.35
First«1 of 3»Last
  • Insiders are both buying and selling Arcutis Biotherapeutics Inc stock.

  • The insider traders at Arcutis Biotherapeutics Inc are: Todd Franklin Watanabe, Howard G Welgus, Patrick Burnett, Masaru Matsuda, Bhaskar Chaudhuri, Scott L Burrows, John W. Smither, Patricia A Turney, Orbimed Advisors Llc, Life Sciences Viii L Frazier, Larry Todd Edwards, Howard G. Welgus, David W Osborne, Welgus Howard G., Terrie Curran, David Joseph Topper, Watanabe Todd Franklin, Jonathan Silverstein, David W. Osborne, and OSBORNE DAVID W

  • The most active insider trader at Arcutis Biotherapeutics Inc is Todd Franklin Watanabe with 28 trades.

  • Orbimed Advisors Llc has sold the most Arcutis Biotherapeutics Inc stock with a total value of $25,610,794.78.

  • Jonathan Silverstein has bought the most Arcutis Biotherapeutics Inc stock with a total value of $28,659,776.64.

  • The most recent insider trade for Arcutis Biotherapeutics Inc was on Nov. 15, 2024.

  • The single biggest insider buy for Arcutis Biotherapeutics Inc was from Jonathan Silverstein with a total value of $14,329,888.32 on Feb. 3, 2020.

  • The single biggest insider sell for Arcutis Biotherapeutics Inc was from Orbimed Advisors Llc with a total value of $7,287,402.01 on June 24, 2022.